Publications by authors named "H Richly"

Claim this Profile
S
Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).
Halime Kalkavan, Max E Scheulen, Eckhart Kämpgen, Ulrich Keilholz, Lucie Heinzerling, Heike Richly

iScience· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and radiomics parameter prognostication in metastatic uveal melanoma patients treated with hepatic arterial infusion chemotherapy.
Tanja Gromke, Juliane Durand, Tamara T Mueller, Felix Neumaier, Sven T Liffers, Heike Richly

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradable Starch Microsphere Transarterial Chemoembolization as Salvage Therapy in Patients with Uveal Melanoma Liver Metastases.
Hannah L Steinberg-Vorhoff, Johannes Haubold, Sebastian Bauer, Heike Richly, Jens T Siveke

J Vasc Interv Radiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of the respiratory chain by a mitochondrial distress-related redox signal.
Marius W Baeken, Ankush Borlepawar, Philipp Kötzner, Holger Richly, Christian Behl

Front Cell Dev Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does volume change of the spleen correlate with the therapy response in uveal melanoma patients with liver metastases undergoing hepatic artery infusion chemotherapy?
Hannah Luisa Steinberg-Vorhoff, Marcel Drews, Marcel Opitz, Natalie van Landeghem, Luca Salhöfer, Heike Richly

Radiol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis